Dudediligence.

Q32 Bio Inc

QTTBNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24
Net income, by quarter
−$17.6MSep ’24−$14.2MDec ’24−$11.0MMar ’25−$9.5MJun ’25−$7.4MSep ’25$57.7MDec ’25−$7.6MMar ’26−$8.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$34.0M$3.2M$1.2M$0.00$53.7M
Operating income−$95.9M−$133.3M−$48.3M−$66.1M$16.9M
Net income−$95.8M−$5.0M−$53.7M−$47.7M$29.8M
Operating cash flow−$109.8M−$113.7M−$18.7M−$67.7M−$33.5M
Free cash flow−$112.1M−$114.9M−$18.7M−$67.8M−$33.5M
Cash$108.4M$34.0M$25.6M$78.0M$48.3M
Shares outstanding57.2M57.5M359.6K12.2M12.9M